Amicus Therapeutics, Inc.
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults wit…
Biotechnology
US, Philadelphia [HQ]
Ratios
15 Sheets · From 2023 to 2009Configuration
Margins, Growth Rates In %
| Ratio | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||||||||
| Gross Margin | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | - - | 83.20 | 83.11 | 84.21 | 87.95 | 88.10 | 88.72 | 88.28 | 88.68 | |
| Profit Margin | -10.20 | -5,958.35 | -207.20 | -264.98 | -16,427.82 | -5,631.21 | - - | -4,034.73 | -769.03 | -382.48 | -195.56 | -106.12 | -81.98 | -71.85 | -37.96 | |
| Operating Margin | -11.42 | -6,056.18 | -237.41 | -287.50 | -17,680.72 | -5,612.83 | - - | -3,668.62 | -1,196.82 | -360.32 | -165.03 | -93.47 | -65.44 | -62.09 | -18.40 | |
|
EPS Growth
|
83.43 | -582.76 | 35.35 | 16.41 | -8.41 | 19.83 | -29.03 | -24.17 | -24.16 | -1.62 | 21.28 | 27.70 | 14.02 | 10.87 | 37.81 | |
| EPS USD | -29.00 | -198.00 | -128.00 | -107.00 | -116.00 | -93.00 | -120.00 | -149.00 | -185.00 | -188.00 | -148.00 | -107.00 | -92.00 | -82.00 | -51.00 | |
| Return on Assets (ROA) | -7.69 | -48.81 | -63.63 | -44.31 | -46.75 | -32.83 | -14.54 | -19.29 | -45.29 | -44.18 | -41.92 | -31.23 | -27.67 | -32.67 | -19.49 | |
| Return on Equity (ROE) | -9.14 | -84.60 | -150.08 | -70.48 | -130.34 | -56.41 | -37.98 | -55.54 | -80.49 | -101.77 | -74.80 | -96.67 | -81.49 | -192.26 | -94.64 | |
| Return on Invested Capital (ROIC) | -10.12 | -81.32 | -153.55 | -70.98 | -100.64 | -49.52 | -33.87 | -34.68 | -54.03 | -49.45 | -43.86 | -33.81 | -27.73 | -34.74 | -13.34 | |
| Solvency | ||||||||||||||||
| Equity Ratio | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Debt/Assets | 4.57 | 2.08 | 1.50 | 0.63 | 11.35 | 6.83 | 4.58 | 14.93 | 26.23 | 40.73 | 24.73 | 49.83 | 48.63 | 62.43 | 50.93 | |
| Debt/Equity | 5.43 | 3.60 | 3.53 | 1.01 | 31.63 | 11.75 | 11.96 | 42.97 | 46.61 | 93.83 | 44.13 | 154.25 | 143.19 | 367.44 | 247.35 | |
| Debt/EBITDA | 571.95 | 50.79 | 50.11 | 65.39 | 48.37 | 14.52 | 22.60 | 18.61 | -58.53 | -76.48 | -20.49 | -119.75 | -99.40 | -158.07 | -301.83 | |
|
Debt/Capitalization
|
5.15 | 3.47 | 3.41 | 1.00 | 24.03 | 10.51 | 10.68 | 30.05 | 31.79 | 48.41 | 30.62 | 60.67 | 58.88 | 78.61 | 71.21 | |
| Long-Term Debt/Capitalization | 3.16 | 1.58 | - - | 0.43 | 23.65 | 7.92 | 10.68 | 30.02 | 31.75 | 48.41 | 29.88 | 60.29 | 58.47 | 78.28 | 70.77 | |
| Interest Debt per Share USD | 0.18 | 0.09 | 0.03 | 0.02 | 0.28 | 0.21 | 0.39 | 1.19 | 1.18 | 1.85 | 0.95 | 1.79 | 1.74 | 1.69 | 1.51 | |
| Debt Growth | 226.80 | -40.11 | -55.33 | -33.24 | 1,976.47 | -0.85 | 189.90 | 271.30 | 6.48 | 95.62 | -34.66 | 110.12 | -0.36 | 2.72 | -1.56 | |
| Liquidity | ||||||||||||||||
| Current Ratio | 719.07 | 676.08 | 346.12 | 1,131.85 | 843.88 | 765.80 | 294.23 | 306.48 | 559.63 | 639.88 | 403.75 | 446.86 | 408.86 | 304.86 | 288.07 | |
| Quick Ratio | 698.87 | 662.30 | 315.46 | 1,107.29 | 791.12 | 751.42 | 290.74 | 298.90 | 525.45 | 610.87 | 377.31 | 408.86 | 366.62 | 258.81 | 222.93 | |
| Cash Ratio | 172.78 | 182.28 | 133.30 | 367.53 | 417.17 | 119.27 | 94.39 | 168.55 | 70.05 | 92.60 | 110.89 | 125.88 | 167.97 | 107.05 | 147.29 | |
| Operating Cash Flow Ratio | -300 | - - | -200 | -300 | -400 | -200 | -100 | -100 | -300 | -300 | -100 | -100 | -100 | -100 | - - | |
| Turnover | ||||||||||||||||
| Inventory Turnover | - - | - - | - - | - - | - - | - - | - - | 24.39 | 134.89 | 171.68 | 156.42 | 158.74 | 128.52 | 162.07 | 75.72 | |
| Receivables Turnover | - - | - - | 425.03 | 570.88 | 47.83 | - - | - - | 380.22 | 390.22 | 415.47 | 547.52 | 555.99 | 580.03 | 497.36 | 455.72 | |
| Payables Turnover | - - | - - | - - | - - | - - | - - | - - | 2.03 | 79.27 | 17.87 | 18.25 | 181.94 | 160.21 | 250.43 | 298.94 | |
|
Asset Turnover
|
75.39 | 0.82 | 30.71 | 16.72 | 0.28 | 0.58 | - - | 0.48 | 5.89 | 11.55 | 21.43 | 29.43 | 33.75 | 45.46 | 51.34 | |
| Fixed Turnover | 1,463.01 | 35.41 | 879.16 | 366.10 | 8.81 | 43.54 | - - | 50.51 | 407.53 | 802.15 | 224.93 | 388.46 | 484.31 | 545.88 | 688.79 | |
| Coverage | ||||||||||||||||
| Interest Coverage | -2,643.88 | -21,476.15 | -34,383.11 | -59,473.03 | -139,523.91 | -4,629.45 | -8,265.97 | -3,369.58 | -2,563.72 | -1,467.62 | -1,593.58 | -1,087.42 | -615.69 | -550.73 | -146.55 | |
| Asset Coverage | 1,900 | 4,100 | 4,900 | 14,500 | 600 | 1,100 | 800 | 200 | 300 | 200 | 300 | 100 | 100 | 100 | 100 | |
| Cash Flow Coverage (CFGR) | -1,111.51 | -598.33 | -4,733.91 | -4,841.32 | -316.41 | -360.06 | -240.71 | -97.28 | -131.01 | -93.23 | -119.12 | -52.81 | -46.01 | -36.84 | -17.44 | |
| EBITDA Coverage | -900 | -20,600 | -33,200 | -57,100 | -131,000 | -4,500 | -7,800 | -3,200 | -1,100 | -1,400 | -1,700 | -1,000 | -600 | -500 | -100 | |
| Dividend Coverage | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Time Interest Earned (TIE) | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Market Prospects | ||||||||||||||||
| Dividend Yield | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Earnings Yield | -7.31 | -42.14 | -37.35 | -39.95 | -49.48 | -11.13 | -12.39 | -29.95 | -12.87 | -19.61 | -15.22 | -4.63 | -7.99 | -6.70 | -3.62 | |
|
Price/Earnings (P/E)
|
-1,367.71 | -237.28 | -267.76 | -250.31 | -202.11 | -898.61 | -807.05 | -333.92 | -777.03 | -510.00 | -657.06 | -2,159.00 | -1,251.67 | -1,491.91 | -2,763.08 | |
| Price/Earnings Growth (PEG) | 16.39 | -0.41 | 7.57 | 15.26 | -24.03 | 45.32 | -27.80 | -13.82 | -32.16 | -314.50 | 30.88 | 77.93 | 89.29 | 137.26 | 73.09 | |
|
Price/Book (P/B)
|
125.04 | 200.75 | 401.86 | 176.42 | 263.43 | 506.95 | 306.54 | 185.47 | 625.42 | 519.05 | 491.52 | 2,087.17 | 1,019.92 | 2,868.33 | 2,614.90 | |
| Price/Tangible Book (P/TB) | 125.04 | 200.75 | 401.86 | 176.42 | 263.43 | 506.95 | 306.54 | 185.47 | 625.42 | 519.05 | 491.52 | 2,087.17 | 1,019.92 | 2,868.33 | 2,614.90 | |
| Price/Sales (P/S) | 139.56 | 14,138.13 | 554.82 | 663.27 | 33,201.72 | 50,602.56 | - - | 13,472.69 | 5,975.58 | 1,950.65 | 1,284.98 | 2,291.13 | 1,026.11 | 1,072.00 | 1,048.78 | |
|
Price/Cash Flow (P/CF)
|
-207.09 | -932.23 | -240.62 | -361.89 | -263.18 | -1,198.74 | -1,064.78 | -443.74 | -1,024.10 | -593.38 | -935.12 | -2,562.15 | -1,548.18 | -2,118.80 | -6,062.13 | |
| Price/Free CF (P/FCF) | -198.81 | -907.31 | -233.90 | -320.78 | -259.25 | -1,193.24 | -1,015.91 | -426.86 | -1,003.03 | -581.16 | -865.92 | -2,527.20 | -1,519.04 | -2,071.95 | -5,472.79 | |
| Price/Operating CF (P/OCF) | -207.09 | -932.23 | -240.62 | -361.89 | -263.18 | -1,198.74 | -1,064.78 | -443.74 | -1,024.10 | -593.38 | -935.12 | -2,562.15 | -1,548.18 | -2,118.80 | -6,062.13 |